cancer drugs

Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

The problems lie not with ITM-11's efficacy or safety but with its CMC and with a third-party commercial facility.

Darren Incorvaia Aug 10, 2026 11:25am

Recipharm

CDMO Recipharm to pump ‘multi-million-dollar' investment into US

Jun 16, 2026 8:49am

Niowave

Niowave starts building $75M plant to boost radioisotope supply

May 26, 2026 8:35am

dart board miss failure

Fierce Biotech

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm

FDA

ImmunityBio hit with FDA warning letter over Anktiva promotions

Mar 24, 2026 1:15pm

deal handshake business cooperation partnerships

Novartis taps Niowave for supply of radiopharmaceutical isotope

Feb 17, 2026 8:45am